Lataa…
Protection is not always a good thing: The immune system’s impact on gene therapy
There are many clinical trials underway for the development of gene therapies, and some have resulted in gene therapy products being commercially approved already. Significant progress was made to develop safer and more effective strategies to deliver and regulate genetic products. An unsolved aspec...
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Online Artikkeli Teksti |
| Kieli: | English |
| Julkaistu: |
Sociedade Brasileira de Genética
2022
|
| Aiheet: | |
| Linkit: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295005/ https://www.ncbi.nlm.nih.gov/pubmed/35852088 http://dx.doi.org/10.1590/1678-4685-GMB-2022-0046 |